Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Formos Med Assoc ; 120(1 Pt 3): 668-678, 2021 Jan.
Article in English | MEDLINE | ID: mdl-32800657

ABSTRACT

BACKGROUND/PURPOSE: Arecoline, the major alkaloid of areca nut, is known to induce reactive oxygen species (ROS) and DNA damage during oral cancer progression. This study aim to evaluate whether melatonin, an antioxidant, supported or repressed the arecoline-induced carcinogenesis phenotypes in oral squamous cell carcinoma (OSCC). METHODS: The cytotoxicity of arecoline or melatonin treatment alone and their co-treatment in the OSCC cell line OEC-M1 were analyzed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The cell cycle, cell death, and total ROS production were analyzed using flow cytometer. The protein expression was determined using western blot analysis. The genotoxicity and mutation rate were determined using micronucleus assay and hypoxanthine phosphoribosyl transferase (HPRT) forward mutation assay, respectively, in CHO-K1 cells. The ataxia telangiectasia mutated (ATM) promoter activity and DNA repair ability were determined through reporter assay. RESULTS: The result showed that both the arecoline and melatonin induced ROS production and antioxidant enzymes expression. Melatonin treatment enhanced arecoline-induced ROS production, cytotoxicity, G2/M phase arrest, and cell apoptosis in OSCC cells. On the other hand, melatonin treatment activated DNA repair activity to reverse arecoline-induced DNA damage and mutation. CONCLUSION: These results indicated that melatonin is a potential chemopreventive agent for betel quid chewers to prevent OSCC initiation and progression.


Subject(s)
Carcinoma, Squamous Cell , Mouth Neoplasms , Areca , Arecoline/toxicity , Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/genetics , DNA Damage , Humans , Melatonin/pharmacology , Mouth Neoplasms/drug therapy , Mouth Neoplasms/genetics , Reactive Oxygen Species , Squamous Cell Carcinoma of Head and Neck
2.
J Formos Med Assoc ; 118(10): 1458-1465, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31358435

ABSTRACT

BACKGROUND/PURPOSE: Mineral trioxide aggregate (Pro-Root MTA, PR-MTA) and bioceramics (iRoot® SP Injectable Root Canal Sealer, iR-BC) are used for making apical plugs used in apexification, repairing root perforations during root canal therapy, and treating internal root resorption. The purpose of the present in vitro study was to compare the biological effects of PR-MTA- and iR-BC-based dental sealers in the mouse macrophage cell line RAW 264.7. METHODS: Cytotoxicity and cell proliferation were analyzed using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and cell hemocytometer, respectively. Protein expression of biomarkers of cell proliferation, autophagy, and osteoclast differentiation was determined by western blotting. Pro-inflammatory gene expression was examined using quantitative reverse transcription-PCR. RESULTS: PR-MTA induced cytotoxicity in RAW 264.7 cells in a dose-dependent manner, and iR-BC was more cytotoxic than PR-MTA. Low-dose and short-term treatments of both PR-MTA and iR-BC induced RAW 264.7 cell proliferation. PR-MTA induced autophagy, whereas iR-BC did not. Neither PR-MTA nor iR-BC induced osteoclastogenesis. Pro-inflammatory genes were activated by both materials. However, the expression of inducible nitric oxide synthase (iNOS) mRNA was upregulated by iR-BC treatment, but not by PR-MTA treatment. CONCLUSION: Overall, dental PR-MTA and iR-BC induced pro-inflammatory genes but did not induce osteoclastogenesis in macrophages. PR-MTA and iR-BC induced M2 and M1 polarization, respectively, of RAW 264.7 cells.


Subject(s)
Aluminum Compounds/pharmacology , Calcium Compounds/pharmacology , Cell Differentiation/drug effects , Cell Polarity/drug effects , Oxides/pharmacology , Root Canal Filling Materials/pharmacology , Silicates/pharmacology , Animals , Autophagy/drug effects , Cell Proliferation/drug effects , Cell Survival/drug effects , Ceramics/pharmacology , Cyclooxygenase 2/genetics , Drug Combinations , Gene Expression/drug effects , Inflammation/genetics , Interleukin-1beta/genetics , Interleukin-6/genetics , Mice , Nitric Oxide Synthase Type II/genetics , Osteogenesis/drug effects , RAW 264.7 Cells , RNA, Messenger/metabolism , Tumor Necrosis Factor-alpha/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...